ASCO and the CAP Release Updated Guideline on HER2 Testing in Breast Cancer
Tuesday, October 8, 2013 - 10:00
in Health & Medicine
The American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) today issued a joint, updated guideline aimed at improving the accuracy and reporting of human epidermal growth factor receptor 2 (HER2) testing in patients with invasive breast cancer.